Buy Retatrutide 40mg: Triple Agonist Peptide for Metabolic & Obesity Research

Retatrutide (40mg) is a powerful triple hormone receptor agonist that simultaneously activates GLP-1, GIP, and glucagon receptors. This 40mg research vial offers a balanced high-strength option, making it ideal for medium-to-high dose studies, extended metabolic research, and advanced obesity models. Retatrutide is one of the most promising peptides currently studied for superior weight loss, appetite suppression, energy expenditure, glucose control, and fat metabolism.

Molecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈ Molecular Weight: 4813.5 g/mol (approximate) Purity: ≥99% (lyophilized, research-grade)

Important Notice: This peptide is strictly intended for research and laboratory use only. Not for human consumption, diagnostic, therapeutic, or veterinary purposes. Please review and agree to our Terms and Conditions before ordering.

What is Retatrutide?

Retatrutide is a synthetic multi-agonist peptide designed to target three key metabolic hormone pathways simultaneously:

• GLP-1 receptor — for appetite suppression and glucose-dependent insulin secretion
• GIP receptor — for enhanced insulin sensitivity and lipid metabolism
• Glucagon receptor — for increased energy expenditure and lipolysis

This triple mechanism provides more comprehensive metabolic effects than dual agonists like tirzepatide, positioning Retatrutide as a leading compound in current incretin and obesity research.

Mechanism of Action in Research

In experimental models, Retatrutide:

• Strongly suppresses appetite and reduces caloric intake
• Increases energy expenditure through glucagon receptor activation
• Promotes significant reduction in body weight and visceral fat
• Improves insulin sensitivity and glycemic control
• Enhances lipid profiles and cardiometabolic markers

Research suggests Retatrutide may deliver superior weight loss results compared to existing dual GLP-1/GIP agonists.

Key Research Areas

The 40mg strength is particularly suitable for:

• Medium-to-high dose response studies
• Chronic administration and long-term metabolic models
• Obesity and type 2 diabetes research
• Energy balance and thermogenesis experiments
• Comparative triple vs. dual agonist studies

Research Applications

The 40mg vial supports:

• Dose-escalation and extended treatment protocols
• Animal models of severe obesity and metabolic syndrome
• Body composition and visceral fat analysis
• Pharmacokinetic and long-term efficacy studies
• Multi-receptor agonist comparative investigations

Reconstitution is typically performed with bacteriostatic water for flexible laboratory dosing.

Why Choose 99% Pure Retatrutide 40mg?

Our Retatrutide 40mg delivers ≥99% purity for reliable, reproducible results in receptor activation, appetite regulation, and metabolic outcome studies. Third-party tested and lyophilized for optimal stability in advanced research settings.

In summary, Retatrutide 40mg is a high-potency triple agonist peptide for advanced research into weight loss, obesity, glucose control, energy expenditure, and metabolic health. Elevate your incretin and multi-agonist studies with this premium research tool.